Cargando…
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017–2019
INTRODUCTION: Hepatitis C virus (HCV) is the most common bloodborne chronic infection in the US. Following approval of highly effective, direct-acting antivirals in 2014, the diagnostic and treatment rates for HCV infection in the US have evolved. This study assessed the number of individuals with H...
Autores principales: | Reau, Nancy, Sulkowski, Mark S., Thomas, Emmanuel, Sundaram, Vinay, Xu, Qingqing, Cheng, Wei-Han, Marx, Steven E., Hayes, Oscar A., Manthena, Shivaji R., Chirikov, Viktor, Dylla, Douglas E., Brooks, Hannah, Carabino, Jana M., Saab, Sammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548268/ https://www.ncbi.nlm.nih.gov/pubmed/34704194 http://dx.doi.org/10.1007/s12325-021-01928-y |
Ejemplares similares
-
Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida
por: Thomas, Emmanuel, et al.
Publicado: (2021) -
Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study
por: Martinez, Anthony, et al.
Publicado: (2023) -
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
por: Suraweera, Duminda, et al.
Publicado: (2016) -
Estimating the Year Each State in the United States Will Achieve the World Health Organization’s Elimination Targets for Hepatitis C
por: Sulkowski, Mark, et al.
Publicado: (2020) -
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
por: Reau, Nancy, et al.
Publicado: (2023)